Joel C. Joyce

501 total citations
19 papers, 368 citations indexed

About

Joel C. Joyce is a scholar working on Dermatology, Epidemiology and Surgery. According to data from OpenAlex, Joel C. Joyce has authored 19 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Dermatology, 6 papers in Epidemiology and 4 papers in Surgery. Recurrent topics in Joel C. Joyce's work include Dermatology and Skin Diseases (6 papers), Microscopic Colitis (4 papers) and Drug-Induced Adverse Reactions (3 papers). Joel C. Joyce is often cited by papers focused on Dermatology and Skin Diseases (6 papers), Microscopic Colitis (4 papers) and Drug-Induced Adverse Reactions (3 papers). Joel C. Joyce collaborates with scholars based in United States, Spain and Canada. Joel C. Joyce's co-authors include Peter Higgins, Akbar K. Waljee, Sijian Wang, Ji Zhu, Tahira Khan, Patricia A. Wren, Laura A. Johnson, Konstantinos Katsanos, Anthony Lopez and Jonathan M. Rubin and has published in prestigious journals such as Gastroenterology, Journal of Allergy and Clinical Immunology and The Journal of Pediatrics.

In The Last Decade

Joel C. Joyce

14 papers receiving 363 citations

Peers

Joel C. Joyce

GENET

EPIDE

SURGE

IMMUN

ONCOL

Zsolt Tarján Hungary

Romain Gérard France

Tamás Györke Hungary

Marta Vernero Italy

Samuel C. Smith United Kingdom

Antony B. Friedman Australia

Anna Fábián Hungary

Cristina Bezzio Italy

Lucas Guillo France

Elena Di Girolamo Italy

Zsolt Tarján Hungary

Joel C. Joyce

206 ×0.9

GENET

155 ×0.8

EPIDE

150 ×1.7

SURGE

43 ×0.9

IMMUN

39 ×0.9

ONCOL

Citations per year, relative to Joel C. Joyce Joel C. Joyce (= 1×) peers Zsolt Tarján

Countries citing papers authored by Joel C. Joyce

Since Specialization

Citations

This map shows the geographic impact of Joel C. Joyce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel C. Joyce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel C. Joyce more than expected).

Fields of papers citing papers by Joel C. Joyce

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel C. Joyce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel C. Joyce. The network helps show where Joel C. Joyce may publish in the future.

Co-authorship network of co-authors of Joel C. Joyce

This figure shows the co-authorship network connecting the top 25 collaborators of Joel C. Joyce. A scholar is included among the top collaborators of Joel C. Joyce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel C. Joyce. Joel C. Joyce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Paller, Amy S., Danielle Marcoux, Michele Ramien, et al.. (2025). Systemic Treatments in Moderate-to-Severe Atopic Dermatitis in Pediatric Patients up to 12 Years of Age: Real-World Treatment Outcomes from the PEDISTAD Registry. American Journal of Clinical Dermatology. 26(6). 1031–1043.

Mehlis, Stephanie, et al.. (2024). Updates in atopic dermatitis for the primary care physician: A review of advances in the understanding and treatment of atopic dermatitis. Disease-a-Month. 70(4). 101687–101687. 4 indexed citations

Paller, Amy S., Marjolein de Bruin‐Weller, Danielle Marcoux, et al.. (2024). Real-world treatment outcomes of systemic treatments for moderate-to-severe atopic dermatitis in children aged less than 12 years: 2-year results from PEDIatric STudy in Atopic Dermatitis. Journal of the American Academy of Dermatology. 92(2). 242–251. 2 indexed citations

Beck, Lisa A., Eric L. Simpson, Michele Ramien, et al.. (2024). 686 - Impact of dupilumab treatment on seasonal disease severity in adults with moderate-to-severe atopic dermatitis. British Journal of Dermatology. 191(Supplement_2).

Soong, Weily, Andrea L. Zaenglein, Megha M. Tollefson, et al.. (2024). Efficacy and Safety of Ruxolitinib Cream Among Children With Atopic Dermatitis Aged 2 to 6 Years and 7 to <12 Years: Results from a Phase 3 Double-Blind Vehicle-Controlled Study. Journal of Allergy and Clinical Immunology. 153(2). AB1–AB1. 1 indexed citations

Marcoux, Danielle, Michele Ramien, Martti Antila, et al.. (2023). 43740 The Effect of Systemic Treatment on Different Anatomical Regions in Pediatric Patients with Atopic Dermatitis: Real-World Data from PEDISTAD. Journal of the American Academy of Dermatology. 89(3). AB233–AB233.

Cibull, Thomas L., et al.. (2021). Development of drug‐induced psoriasiform alopecia in a pediatric patient on ustekinumab. Journal of Cutaneous Pathology. 48(12). 1523–1525. 2 indexed citations

Joyce, Joel C., et al.. (2018). Postpartum eruption of enoxaparin‐induced erythema multiforme. Clinical Case Reports. 6(10). 1966–1969. 1 indexed citations

Joyce, Joel C., et al.. (2016). Pseudoarthrosis of the Ulna in Neurofibromatosis Type I. The Journal of Pediatrics. 177. 330–330.

10.

Joyce, Joel C., et al.. (2014). Pyoderma gangrenosum: a possible cutaneous complication of levamisole‐tainted cocaine abuse. International Journal of Dermatology. 54(9). 1075–1077. 13 indexed citations

11.

Wilson, Barbara, et al.. (2014). Toxic epidermal necrolysis due to voriconazole: case report and review. Dermatology Online Journal. 20(9). 9 indexed citations

12.

Joyce, Joel C., et al.. (2014). Superficial Hemosiderotic Lymphovascular Malformation (Hobnail Hemangioma): A Report of Six Cases. Pediatric Dermatology. 31(3). 281–285. 1 indexed citations

13.

Magro, Fernando, Laurent Peyrin‐Biroulet, Harry Sokol, et al.. (2013). Extra-intestinal malignancies in inflammatory bowel disease: Results of the 3rd ECCO Pathogenesis Scientific Workshop (III). Journal of Crohn s and Colitis. 8(1). 31–44. 117 indexed citations

14.

Johnson, Laura A., Shail M. Govani, Joel C. Joyce, et al.. (2011). Spironolactone and Colitis: Increased Mortality in Rodents and in Humans. Inflammatory Bowel Diseases. 18(7). 1315–1324. 12 indexed citations

15.

Johnson, Laura A., Shail M. Govani, Joel C. Joyce, & Peter Higgins. (2011). Spironolactone Inhibits TGFβ-Induced Fibrogenisis In Vitro but is Associated With Increased Mortality In Vivo. Gastroenterology. 140(5). S–649.

16.

Waljee, Akbar K., Joel C. Joyce, Patricia A. Wren, Tahira Khan, & Peter Higgins. (2009). Patient reported symptoms during an ulcerative colitis flare: A Qualitative Focus Group Study. European Journal of Gastroenterology & Hepatology. 21(5). 558–564. 43 indexed citations

17.

Waljee, Akbar K., Joel C. Joyce, Sijian Wang, et al.. (2009). Algorithms Outperform Metabolite Tests in Predicting Response of Patients With Inflammatory Bowel Disease to Thiopurines. Clinical Gastroenterology and Hepatology. 8(2). 143–150. 67 indexed citations

18.

Kim, Kang, Laura A. Johnson, Congxian Jia, et al.. (2008). Noninvasive Ultrasound Elasticity Imaging (UEI) of Crohn's Disease: Animal Model. Ultrasound in Medicine & Biology. 34(6). 902–912. 68 indexed citations

19.

Joyce, Joel C., Akbar K. Waljee, Tahira Khan, et al.. (2008). Identification of symptom domains in ulcerative colitis that occur frequently during flares and are responsive to changes in disease activity. Health and Quality of Life Outcomes. 6(1). 69–69. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact